Pricing

Log inSign up

Stoke Therapeutics

94 people · 0 jobs
‌

Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Industries

Biotechnology

Headquarters

Bedford, United States

Employees

51-200

Links

Org chart

Edward M. Kaye
CEO & Director
Collapse
Stephen J. Tulipano
CFO
Dawn Kalmar
Chief Communications Officer
Barry S. Ticho
Chief Medical Officer
Jonathan Allan
General Counsel
Isabel Aznarez
Co-Founder & VP, Discovery Research
CB
Christy Chaves Blaney
Senior Director, Head Of Talent Acquisition
KP
Kimberly Parkerson
Senior Vice President, Head Of Neurology Clinical Development
Lorene Kush
Executive Assistant To Chief Executive Officer
SY
Stephen Yu
VP Head of IT
Jason Hoitt
Chief Patient Officer
EO
Eric Olson
Chief Business Officer
Joan Wood
CHRO

Board & advisors

SH
Seth L. Harrison
Chairman
AK
Adrian Krainer
Co-Founder & Director
Jennifer Burstein
Director
Arthur Levin
Director
Garry E. Menzel
Director
Julie Anne Smith
Director
Arthur Tzianabos
Director

Teams

AK
+26

Research and Development

30 people · 0 jobs

+8

Clinical Operations

12 people · 0 jobs

+3

Leadership Team

7 people · 0 jobs

+1

Clinical Operations

5 people · 0 jobs

CB
TB

Operations and Compliance

4 people · 0 jobs

JK

Research and Development

4 people · 0 jobs

Offices

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

161 followers

Regeneron

132 followers

Illumina

79 followers

Agilent Technologies

82 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

45 followers

Explore companies